Skip to content

Medical-device intelligence

Apex BioTechnology Corp.: FDA clearances and recalls

Research Apex BioTechnology Corp. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

35 clearance records and 0 recall records in the covered releases, across 1 source company names and 5 product codes. Dated history runs from Jan 22, 2001 to Apr 4, 2025.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

35 matching records
Device / recordCompany in FDA recordSourceSource date
AUTOSURE VOICE II BLOOD GLUCOSE MONITORING SYSTEM AND TEST STRIPSK102037 · CGAApex BioTechnology Corp.510(k)Aug 13, 2010FDA decision date
CONTREX PLUS LOW CONTROL SOLUTIONK100747 · JJXApex BioTechnology Corp.510(k)Apr 14, 2010FDA decision date
AUTOSURE VOICE BLOOD GLUCOSE MONITORING SYSTEM, MODEL AS90011F9K090043 · CGAApex BioTechnology Corp.510(k)Apr 9, 2009FDA decision date
GLUCOSURE STAR BLOOD GLUCOSE MONITORING SYSTEM, MODEL AS90000E1K073648 · CGAApex BioTechnology Corp.510(k)Apr 10, 2008FDA decision date
GLUCOSURE VOICE BLOOD GLUCOSE MONITORING SYSTEM, MODEL AS90011E1K073137 · NBWApex BioTechnology Corp.510(k)Apr 1, 2008FDA decision date
ASSURE 4 BLOOD GLUCOSE MONITORING SYSTEMK070088 · NBWApex BioTechnology Corp.510(k)Feb 16, 2007FDA decision date
GLUCO TRACK BLOOD GLUCOSE MONITORING SYSTEMK062799 · CGAApex BioTechnology Corp.510(k)Feb 6, 2007FDA decision date
MODIFICATION TO GLUCOSURE BGM SYSTEM, MODEL 221100K011233 · CGAApex BioTechnology Corp.510(k)May 18, 2001FDA decision date
GLUCOSURE BLOOD GLUCOSE MONITORING SYSTEMK002621 · CGAApex BioTechnology Corp.510(k)Jan 22, 2001FDA decision date
GLUCOSMART BLOOD GLUCOSE MONITORING SYSTEMK002624 · CGAApex BioTechnology Corp.510(k)Jan 22, 2001FDA decision date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗